1. Burnet Institute, Melbourne, VIC, Monash Infectious Diseases, Monash Health, Melbourne, VIC, Australia
2. Burnet Institute, Melbourne, VIC, Médecins Sans Frontières (MSF), Manson Unit, London, UK
3. Sydney Infectious Diseases Institute (Sydney ID), and, School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Westmead Hospital, Sydney, NSW
4. Burnet Institute, Melbourne, VIC, Kirby Institute, University of New South Wales, Sydney, NSW, Australia
5. Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, Institute of Clinical Trials and Methodology, University College London, London, UK
6. Médecins Sans Frontières (MSF), Manson Unit, London, UK
7. Interactive Research and Development Global, Singapore City, Singapore
8. UCSF Center for Tuberculosis, Division of Pulmonary and Critical Care Medicine, and
9. UCSF Center for Tuberculosis, Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA
10. Harvard Medical School, Department of Global Health and Social Medicine, Boston, MA
11. Global Alliance for TB Drug Development, New York, NY, USA
12. Victorian Tuberculosis Program, Melbourne Health, Melbourne, VIC, Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia
13. Eswatini National TB Control Program, Mbabane, Kingdom of Eswatini
14. Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, GlaxoSmithKline, London, UK
15. Burnet Institute, Melbourne, VIC, Northern Health Infectious Diseases, Northern Health, Melbourne, VIC
16. School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia
17. Medical Research Council Clinical Trials Unit at University College London, London, UK
18. Médecins Sans Frontières (MSF), Paris, Sorbonne Université, Institut national de la santé et de la recherche médicale, Unité 1135, Centre d’Immunologie et des Maladies Infectieuses, Paris, Assistance
Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries, Paris, France
19. Department of Laboratory Medicine, National University Hospital, Singapore City, Singapore
20. Research Department, Friends for International TB Relief, Ha Noi, Vietnam
21. Infectious Diseases Translational Research Programme, Department of Medicine, National University of Singapore, Singapore City, Division of Infectious Diseases, Department of Medicine, National University Hospital, Singapore City, Institute of
Healthcare Innovation & Technology, National University of Singapore, Singapore City, Singapore
22. The Global Fund, Geneva, Switzerland
23. Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia, Victorian Infectious Disease Unit, Royal Melbourne Hospital, Melbourne, VIC, Australia
24. MSF, Geneva, Switzerland
25. Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, German Center for Infection Research (DZIF), TTU-TB, Borstel, Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany, Baylor College
of Medicine and Texas Children’s Hospital, Houston, TX, USA
26. Department of Infectious Disease, Imperial College London, London, UK, Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Tygerberg, South Africa
27. Public Health Department, Operational Center Amsterdam (OCA), MSF, Amsterdam, The Netherlands
28. Damien Foundation Bangladesh, Dhaka, Bangladesh
29. De La Salle Medical and Health Sciences Institute, Dasmariñas, the Philippines
30. Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, USA
31. Tropical Disease Foundation, Makati City, Manila, the Philippines, KNCV Tuberculosis Foundation, The Hague, The Netherlands
32. Mongolian Anti-TB Coalition, Ulaanbaatar, Mongolia
33. Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute & McGill International TB Centre, Montreal, QC, Canada
34. Centre for Infectious Disease Epidemiology and Research, School of Public Health and Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town
35. TASK Applied Science, Cape Town, South Africa
36. The Republican Scientific and Practical Center for Pulmonology and TB, Minsk, Belarus
37. Treatment Action Group, New York, NY
38. Departments of Global Health, Epidemiology, Biostatistics and Medicine, Schools of Public Health and Medicine, Boston University, Boston MA, USA
39. Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa, Faculty
of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, UK
40. Sydney Infectious Diseases Institute (Sydney ID), and, The Children’s Hospital at Westmead, Sydney, NSW, WHO Collaborating Centre in Tuberculosis, The University of Sydney, Sydney, NSW, Australia